250 related articles for article (PubMed ID: 16785507)
21. Involvement of the kynurenine pathway in human glioma pathophysiology.
Adams S; Teo C; McDonald KL; Zinger A; Bustamante S; Lim CK; Sundaram G; Braidy N; Brew BJ; Guillemin GJ
PLoS One; 2014; 9(11):e112945. PubMed ID: 25415278
[TBL] [Abstract][Full Text] [Related]
22. Tolerance, DCs and tryptophan: much ado about IDO.
Grohmann U; Fallarino F; Puccetti P
Trends Immunol; 2003 May; 24(5):242-8. PubMed ID: 12738417
[No Abstract] [Full Text] [Related]
23. Indolamine 2,3-dioxygenase expression by monocytes and dendritic cell populations in hepatitis C patients.
Schulz S; Landi A; Garg R; Wilson JA; van Drunen Littel-van den Hurk S
Clin Exp Immunol; 2015 Jun; 180(3):484-98. PubMed ID: 25605587
[TBL] [Abstract][Full Text] [Related]
24. Implications of IFN-gamma-mediated tryptophan catabolism on solid organ transplantation.
Brandacher G; Margreiter R; Fuchs D
Curr Drug Metab; 2007 Apr; 8(3):273-82. PubMed ID: 17430115
[TBL] [Abstract][Full Text] [Related]
25. Role of indoleamine 2,3-dioxygenase in acute myeloid leukemia.
Sobash PT; Kolhe R; Karim NA; Guddati AK; Jillella A; Kota V
Future Oncol; 2020 Dec; 16(36):3085-3094. PubMed ID: 32976029
[TBL] [Abstract][Full Text] [Related]
26. Indoleamine 2,3-dioxygenase and dendritic cell tolerogenicity.
Harden JL; Egilmez NK
Immunol Invest; 2012; 41(6-7):738-64. PubMed ID: 23017144
[TBL] [Abstract][Full Text] [Related]
27. Indoleamine 2,3-dioxygenase: from catalyst to signaling function.
Fallarino F; Grohmann U; Puccetti P
Eur J Immunol; 2012 Aug; 42(8):1932-7. PubMed ID: 22865044
[TBL] [Abstract][Full Text] [Related]
28. Differential regulation of indoleamine 2,3-dioxygenase by lipopolysaccharide and interferon gamma in murine bone marrow derived dendritic cells.
Jung ID; Lee CM; Jeong YI; Lee JS; Park WS; Han J; Park YM
FEBS Lett; 2007 Apr; 581(7):1449-56. PubMed ID: 17367785
[TBL] [Abstract][Full Text] [Related]
29. Enhanced tryptophan catabolism in the absence of the molecular adapter DAP12.
Orabona C; Tomasello E; Fallarino F; Bianchi R; Volpi C; Bellocchio S; Romani L; Fioretti MC; Vivier E; Puccetti P; Grohmann U
Eur J Immunol; 2005 Nov; 35(11):3111-8. PubMed ID: 16206234
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites.
Terness P; Bauer TM; Röse L; Dufter C; Watzlik A; Simon H; Opelz G
J Exp Med; 2002 Aug; 196(4):447-57. PubMed ID: 12186837
[TBL] [Abstract][Full Text] [Related]
31. Normal development and function of dendritic cells in mice lacking IDO-1 expression.
de Faudeur G; de Trez C; Muraille E; Leo O
Immunol Lett; 2008 Jun; 118(1):21-9. PubMed ID: 18384884
[TBL] [Abstract][Full Text] [Related]
32. Dendritic cells transfected with indoleamine 2,3-dioxygenase gene suppressed acute rejection of cardiac allograft.
Li C; Liu T; Zhao N; Zhu L; Wang P; Dai X
Int Immunopharmacol; 2016 Jul; 36():31-38. PubMed ID: 27107370
[TBL] [Abstract][Full Text] [Related]
33. Deficient tryptophan catabolism along the kynurenine pathway reveals that the epididymis is in a unique tolerogenic state.
Jrad-Lamine A; Henry-Berger J; Gourbeyre P; Damon-Soubeyrand C; Lenoir A; Combaret L; Saez F; Kocer A; Tone S; Fuchs D; Zhu W; Oefner PJ; Munn DH; Mellor AL; Gharbi N; Cadet R; Aitken RJ; Drevet JR
J Biol Chem; 2011 Mar; 286(10):8030-8042. PubMed ID: 21189261
[TBL] [Abstract][Full Text] [Related]
34. Association of Increased Treg Cell Levels With Elevated Indoleamine 2,3-Dioxygenase Activity and an Imbalanced Kynurenine Pathway in Interferon-Positive Primary Sjögren's Syndrome.
Maria NI; van Helden-Meeuwsen CG; Brkic Z; Paulissen SM; Steenwijk EC; Dalm VA; van Daele PL; Martin van Hagen P; Kroese FG; van Roon JA; Harkin A; Dik WA; Drexhage HA; Lubberts E; Versnel MA
Arthritis Rheumatol; 2016 Jul; 68(7):1688-99. PubMed ID: 26866723
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of allogeneic T-cell responses by dendritic cells expressing transduced indoleamine 2,3-dioxygenase.
Funeshima N; Fujino M; Kitazawa Y; Hara Y; Hara Y; Hayakawa K; Okuyama T; Kimura H; Li XK
J Gene Med; 2005 May; 7(5):565-75. PubMed ID: 15543532
[TBL] [Abstract][Full Text] [Related]
36. IDO expands human CD4+CD25high regulatory T cells by promoting maturation of LPS-treated dendritic cells.
Hill M; Tanguy-Royer S; Royer P; Chauveau C; Asghar K; Tesson L; Lavainne F; Rémy S; Brion R; Hubert FX; Heslan M; Rimbert M; Berthelot L; Moffett JR; Josien R; Grégoire M; Anegon I
Eur J Immunol; 2007 Nov; 37(11):3054-62. PubMed ID: 17948274
[TBL] [Abstract][Full Text] [Related]
37. Kynurenine is an endothelium-derived relaxing factor produced during inflammation.
Wang Y; Liu H; McKenzie G; Witting PK; Stasch JP; Hahn M; Changsirivathanathamrong D; Wu BJ; Ball HJ; Thomas SR; Kapoor V; Celermajer DS; Mellor AL; Keaney JF; Hunt NH; Stocker R
Nat Med; 2010 Mar; 16(3):279-85. PubMed ID: 20190767
[TBL] [Abstract][Full Text] [Related]
38. Proinflammatory cytokine interferon-gamma increases induction of indoleamine 2,3-dioxygenase in monocytic cells primed with amyloid beta peptide 1-42: implications for the pathogenesis of Alzheimer's disease.
Yamada A; Akimoto H; Kagawa S; Guillemin GJ; Takikawa O
J Neurochem; 2009 Aug; 110(3):791-800. PubMed ID: 19457071
[TBL] [Abstract][Full Text] [Related]
39. Immune cell proliferation is suppressed by the interferon-gamma-induced indoleamine 2,3-dioxygenase expression of fibroblasts populated in collagen gel (FPCG).
Sarkhosh K; Tredget EE; Karami A; Uludag H; Iwashina T; Kilani RT; Ghahary A
J Cell Biochem; 2003 Sep; 90(1):206-17. PubMed ID: 12938169
[TBL] [Abstract][Full Text] [Related]
40. Ligation of B7-1/B7-2 by human CD4+ T cells triggers indoleamine 2,3-dioxygenase activity in dendritic cells.
Munn DH; Sharma MD; Mellor AL
J Immunol; 2004 Apr; 172(7):4100-10. PubMed ID: 15034022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
